Immunohistochemistry (IHC) Market: Trends, Size, Share, and Forecasts
In-Depth Look at the Immunohistochemistry Market Dynamics
Meticulous Research® has released a thorough research report titled "Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast to 2031."
The report forecasts that the global immunohistochemistry market will reach $4.08 billion by 2031, expanding at a CAGR of 7.2% from 2024 to 2031. This growth is driven by an increase in chronic diseases, an aging population, a focus on rare diseases, rising awareness about early detection, growing R&D spending, a boost in drug discovery and development, a rise in infectious diseases, and higher healthcare spending.
Opportunities for growth include the move towards personalized medicine, advancements in genomics and proteomics, and increased automation in immunohistochemistry. However, challenges such as stringent technical standards, regulatory complexities, and the presence of alternative technologies may hinder market growth.
Leading Companies
The global immunohistochemistry market is dominated by key players including F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC (U.S.), Bio-Genex Laboratories (U.S.), CANDOR Bioscience GmbH (Germany), and Innovex Biosciences Inc. (U.S.).
Market Analysis
The immunohistochemistry market is segmented by Offering (Consumables [Reagents {Fixation Reagents, Antigen Retrieval, Buffers, Blocking Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and Counterstain}, and Other Accessories], Equipment [Staining Systems, Imaging Systems, Slide Scanners, and Tissue Microarrays], and Services & Software), Method (Avidin-Biotin Complex, Polymer-Based Immunohistochemistry, Catalyzed Signal Amplification [CSA], Fluorescyl-tyramide Amplification, Improved Catalyzed Signal Amplification [iCSA], Multi-Staining Immunohistochemistry, Labeled Streptavidin Biotin [LSAB], and PAP Method), Process (Sample Preparation, Antigen Retrieval, Background Blocking, Target Detection, and Sample Visualization), Application (Research Applications [Drug Discovery, Agriculture & Animal Research, and Other Applications], and Clinical Applications [Reproductive Health, Oncology, Infectious Disease, and Other Clinical Applications]), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic Institutes & Research Centers, and Other End Users), and Geography. This comprehensive analysis includes a global and regional market overview and competitive landscape.
In 2024, the consumables segment is expected to hold the largest market share, driven by advancements in IHC consumables, the benefits of IHC kits and reagents, and the repeated usage of consumables.
The avidin-biotin complex method is forecasted to dominate in 2024 due to its high affinity for biotin, stability, and resistance to enzymatic reactions.
The clinical applications segment is projected to be the largest in 2024, with a focus on reproductive health, oncology, and infectious diseases, driven by the increasing prevalence of chronic diseases and growing awareness of early diagnosis.
Hospitals and diagnostic laboratories are anticipated to be the largest end-user segment in 2024 due to the expansion of healthcare facilities and the presence of advanced systems and skilled professionals.
Regional Insights
The report covers major regions including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and the Middle East & Africa.
Asia-Pacific is expected to register the highest CAGR during the forecast period, supported by rapid urbanization, increased focus on infectious diseases, and enhanced healthcare infrastructure investments.
Download Sample Report Here @ meticulousresearch.com/download-sample-repo..
Key questions answered in the report:
Which are the high-growth market segments in terms of offerings, method, application, end user, and region/country?
What was the historical market size for immunohistochemistry globally?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the immunohistochemistry market?
Who are the major players in the global immunohistochemistry market?
What is the competitive landscape like, and who are the market leaders in the global immunohistochemistry market?
What are the recent developments in the global immunohistochemistry market?
What are the different strategies adopted by the major players in the global immunohistochemistry market?
What are the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research